Search

everythinglearnresearchcommunity

for

Search:↓

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Better models and evaluation methods for alopecia areata are needed.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.